NASDAQ · STOCK

Dexcom

DXCM Health Care Unknown Updated July 07, 2026
$72.53
52W $54.11 – $89.98
62/100
$27.93B
29.3
1.43
Price History (6M)
AI Committee Verdict
Buy
Conviction: Contested · 60% agreement · 5 analysts
+2.5%
-0.3%
7.20:1
75%
Executive Summary
6 analysts weighed in with 67% agreement on a bullish lean. Growth Analyst: EPS growing 77.5% YoY. Risk Analyst: Bollinger bandwidth of 16.0% signals elevated volatility. Overall recommendation: BUY.
Executive Summary
6 analysts weighed in with 67% agreement on a bullish lean. Growth Analyst: EPS growing 77.5% YoY. Risk Analyst: Bollinger bandwidth of 16.0% signals elevated volatility. Overall recommendation: BUY.
Bull & Bear Case
Bull Case
  • Positive MACD histogram signals bullish momentum.
  • Daily trend: uptrend.
  • Daily uptrend conflicts with weekly downtrend — buying against the higher timeframe trend is higher risk.
  • Bullish candlestick pattern(s) detected: Bullish Engulfing.
  • Bullish candlestick patterns signal potential reversal or continuation of upside.
Bear Case
  • Stochastic RSI (100.0) confirms overbought conditions.
  • Weekly trend is bearish while daily is bullish — against the higher-timeframe trend.
AI Investment Committee
Committee Consensus As of July 07, 2026
Overall Committee Score
62/100
Agreement
60%
Analysts
5
Conviction
Contested
Value Analyst neutral
54 / 100 · High confidence
Fair value -- neither a bargain nor obviously overpriced
+ ROE of 33.8% shows genuine earnings power backing the valuation
− P/E of 30.2 is moderate-to-rich
Growth Analyst bullish
78 / 100 · High confidence
Strong, accelerating growth with consistent execution
+ EPS growing 77.5% YoY
Technical Analyst bullish
61 / 100 · High confidence
Price action is constructive -- trend and momentum agree
+ Price structure making higher highs and higher lows
Risk Analyst bearish
35 / 100 · Low confidence
Elevated risk from leverage, volatility, event exposure, or portfolio concentration -- size accordingly
− Bollinger bandwidth of 16.0% signals elevated volatility
Macro Analyst bullish
70 / 100 · Moderate confidence
Macro backdrop is supportive of risk assets generally, and this name's beta works in its favor
+ Market regime is bullish (Bull market -- normal position sizing)
News Analyst bullish
66 / 100 · Low confidence
News flow and recent filings/analyst actions are net positive
+ News sentiment is positive (+0.27 across 16 articles, 14d)
Open Full Terminal →
Technical Analysis
RSI (14)
65.2
Neutral
MACD Histogram
0.103
Bullish Momentum
Trend Direction
Uptrend
Weekly: Sideways
Market Structure
Mixed
Support
$73.80
Resistance
$75.93
Bollinger %B
0.69
Inside Bands
Price vs Moving Averages
EMA 9
$71.69 Above
EMA 21
$71.23 Above
EMA 50
$69.66 Above
EMA 200
$69.62 Above
Fundamental Analysis
Valuation
21
Growth
76
Profitability
99
Financial Health
95
Valuation
P/E Ratio 29.3×
P/B Ratio 9.43×
PEG Ratio
Dividend Yield
52W High $89.98
52W Low $54.11
Quality & Growth
ROE 3383.0%
ROA 1339.0%
Gross Margin 6343.0%
Operating Margin 2145.0%
Revenue Growth YoY +1615.0%
Debt / Equity 0.47
AI Fundamental Assessment
P/E ratio of 29.3 (moderate relative to a 15-40x range); Price-to-book of 9.4x; Revenue growth (YoY) of 16.1%; EPS growth (YoY) of 77.5%; Return on equity of 33.8%; Return on assets of 13.4%; Net margin of 19.3%; Gross margin of 63.4%; Current ratio of 1.88 (healthy short-term liquidity); Debt-to-equity of 0.47; Most recent quarter beat estimates by 17.0%; EPS growth accelerating (-26.2% -> +24.4% QoQ); Analyst estimates falling over recent quarters
Key Risks
  • Stochastic RSI (100.0) confirms overbought conditions.
  • Weekly trend is bearish while daily is bullish — against the higher-timeframe trend.
This risk summary is generated from quantitative data signals, not qualitative opinion. All investors should conduct their own due diligence. This is not financial advice.
Get the Full DXCM Analysis
Interactive charts · Live committee votes · Trade plan · Paper trading · AI Q&A
Open in Terminal → Mobile